There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Engagement of Toll-like receptors (TLRs) on macrophages leads to activation of the
mitogen-activated protein kinases (MAPKs), which contribute to innate immune responses.
MAPK activity is regulated negatively by MAPK phosphatases (MKPs). MKP-1, the founding
member of this family of dual-specificity phosphatases, has been implicated in regulating
lipopolysaccharide (LPS) responses, but its role in TLR-mediated immune responses
in vivo has not been defined. Here, we show that mice deficient in MKP-1 were highly
susceptible to endotoxic shock in vivo, associated with enhanced production of proinflammatory
cytokines TNF-alpha and IL-6 and an anti-inflammatory cytokine, IL-10. We further
examined the regulation and function of MKP-1 in macrophages, a major cell type involved
in endotoxic shock. MKP-1 was transiently induced by TLR stimulation through pathways
mediated by both myeloid differentiation factor 88 (MyD88) and TIR domain-containing
adaptor inducing IFN-beta (TRIF). MKP-1 deficiency led to sustained activation of
p38 MAPK and c-Jun N-terminal kinase (JNK) in LPS-treated macrophages. In response
to TLR signals, MKP-1-deficient macrophages produced 5- to 10-fold higher IL-10, which
could be blocked by a p38 MAPK inhibitor. Thus, p38 MAPK plays a critical role in
mediating IL-10 synthesis in TLR signaling. TNF-alpha was found to be more abundant
in MKP-1-deficient macrophages within 2 hours of TLR stimulation, but its production
was rapidly down-regulated by IL-10. Our studies demonstrate that MKP-1 attenuates
the activities of p38 MAPK and JNK to regulate both pro- and anti-inflammatory cytokines
in TLR signaling. These results highlight the complex mechanisms by which the MAPKs
regulate innate immunity.
MyD88, originally isolated as a myeloid differentiation primary response gene, is shown to act as an adaptor in interleukin-1 (IL-1) signaling by interacting with both the IL-1 receptor complex and IL-1 receptor-associated kinase (IRAK). Mice generated by gene targeting to lack MyD88 have defects in T cell proliferation as well as induction of acute phase proteins and cytokines in response to IL-1. Increases in interferon-gamma production and natural killer cell activity in response to IL-18 are abrogated. In vivo Th1 response is also impaired. Furthermore, IL-18-induced activation of NF-kappaB and c-Jun N-terminal kinase (JNK) is blocked in MyD88-/- Th1-developing cells. Taken together, these results demonstrate that MyD88 is a critical component in the signaling cascade that is mediated by IL-1 receptor as well as IL-18 receptor.
In the present study we demonstrate that human monocytes activated by lipopolysaccharides (LPS) were able to produce high levels of interleukin 10 (IL-10), previously designated cytokine synthesis inhibitory factor (CSIF), in a dose dependent fashion. IL-10 was detectable 7 h after activation of the monocytes and maximal levels of IL-10 production were observed after 24-48 h. These kinetics indicated that the production of IL-10 by human monocytes was relatively late as compared to the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF alpha), and granulocyte colony-stimulating factor (G-CSF), which were all secreted at high levels 4-8 h after activation. The production of IL-10 by LPS activated monocytes was, similar to that of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF, inhibited by IL-4. Furthermore we demonstrate here that IL-10, added to monocytes, activated by interferon gamma (IFN-gamma), LPS, or combinations of LPS and IFN-gamma at the onset of the cultures, strongly inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF at the transcriptional level. Viral-IL-10, which has similar biological activities on human cells, also inhibited the production of TNF alpha and GM-CSF by monocytes following LPS activation. Activation of monocytes by LPS in the presence of neutralizing anti-IL-10 monoclonal antibodies resulted in the production of higher amounts of cytokines relative to LPS treatment alone, indicating that endogenously produced IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF. In addition, IL-10 had autoregulatory effects since it strongly inhibited IL-10 mRNA synthesis in LPS activated monocytes. Furthermore, endogenously produced IL-10 was found to be responsible for the reduction in class II major histocompatibility complex (MHC) expression following activation of monocytes with LPS. Taken together our results indicate that IL-10 has important regulatory effects on immunological and inflammatory responses because of its capacity to downregulate class II MHC expression and to inhibit the production of proinflammatory cytokines by monocytes.
MAP kinases are among the most ancient signal transduction pathways and are widely used throughout evolution in many physiological processes. In mammalian species, MAP kinases are involved in all aspects of immune responses, from the initiation phase of innate immunity, to activation of adaptive immunity, and to cell death when immune function is complete. In this review, we summarize recent progress in understanding the function and regulation of MAP kinase pathways in these phases of immune responses.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.